Showing results (711-720 of 974) with videos related to
Sort By:
Pageof 98
Future Science OA|April 5, 2021
Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): a population-based studyPellegrino Cerino, Annachiara Coppola, Palmiero Volzone, et al.American Journal of Human Genetics|June 13, 2025
Weighing the evidence on costs and benefits of polygenic risk-based approaches in clinical practice: A systematic review of economic evaluationsLeonardo Maria Siena, Valentina Baccolini, Marianna Riccio, et al.American Journal of Medical Genetics. Part A|December 27, 2023
Late-onset mucopolysaccharidosis type IIIA mimicking Usher syndromeAlessandro De Falco, Marianthi Karali, Chiara Criscuolo, et al.International Journal of Molecular Sciences|December 11, 2022
Autoimmune Neutropenia and Immune-Dysregulation in a Patient Carrying a TINF2 VariantBenedetta Chianucci, Alice Grossi, Gianluca Dell'Orso, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vectorChia-Ling Gau, Robin A Rosenblatt, Vincenzo Cerullo, et al.Biology|April 23, 2022
An Integrated Monitoring Approach to the Evaluation of the Environmental Impact of an Inshore Mariculture Plant (Mar Grande of Taranto, Ionian Sea)Adriana Giangrande, Margherita Licciano, Daniele Arduini, et al.Molecular Therapy. Nucleic Acids|July 10, 2025
Hepatocyte delivery of miR-34b/c reduces hepatic stellate cell activation and improves liver fibrosisPasquale Piccolo, Rosa Ferriero, Claudia Perna, et al.European Journal of Human Genetics : EJHG|June 2, 2019
Microdeletion of pseudogene chr14.232.a affects LRFN5 expression in cells of a patient with autism spectrum disorderGerarda Cappuccio, Sergio Attanasio, Marianna Alagia, et al.Blood|November 13, 2004
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)Daniela Pende, Grazia Maria Spaggiari, Stefania Marcenaro, et al.Journal of Experimental & Clinical Cancer Research : CR|June 22, 1999
GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderlyI Pierri, M Clavio, G Beltrami, et al.Pageof 98